Answer
The estimated total systemic bioavailability of inhaled ipratropium bromide is 7–28%.
Sources for this answer
- Atrovent 250 UDVs, 1 ml / Atrovent UDVs, 2 mlBoehringer Ingelheim Limited · emc · SmPC §5.2 Pharmacokinetic properties · Version 19Document updated
Sources checked